HUP0100639A3 - Use of human alpha1-acid glycoprotein for producing a pharmaceutical preparation - Google Patents

Use of human alpha1-acid glycoprotein for producing a pharmaceutical preparation

Info

Publication number
HUP0100639A3
HUP0100639A3 HU0100639A HUP0100639A HUP0100639A3 HU P0100639 A3 HUP0100639 A3 HU P0100639A3 HU 0100639 A HU0100639 A HU 0100639A HU P0100639 A HUP0100639 A HU P0100639A HU P0100639 A3 HUP0100639 A3 HU P0100639A3
Authority
HU
Hungary
Prior art keywords
producing
pharmaceutical preparation
acid glycoprotein
human alpha1
alpha1
Prior art date
Application number
HU0100639A
Other languages
Hungarian (hu)
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of HUP0100639A1 publication Critical patent/HUP0100639A1/en
Publication of HUP0100639A3 publication Critical patent/HUP0100639A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0100639A 1997-03-10 1998-03-10 Use of human alpha1-acid glycoprotein for producing a pharmaceutical preparation HUP0100639A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0040997A AT405241B (en) 1997-03-10 1997-03-10 USE OF HUMANEM ALPHA1 ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION
PCT/AT1998/000060 WO1998040087A2 (en) 1997-03-10 1998-03-10 USE OF HUMAN α1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION

Publications (2)

Publication Number Publication Date
HUP0100639A1 HUP0100639A1 (en) 2001-08-28
HUP0100639A3 true HUP0100639A3 (en) 2001-09-28

Family

ID=3489866

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100639A HUP0100639A3 (en) 1997-03-10 1998-03-10 Use of human alpha1-acid glycoprotein for producing a pharmaceutical preparation

Country Status (14)

Country Link
EP (1) EP0967986B1 (en)
JP (1) JP2001514629A (en)
AT (2) AT405241B (en)
AU (1) AU6284198A (en)
BR (1) BR9808000A (en)
CA (1) CA2283580A1 (en)
DE (1) DE59805897D1 (en)
DK (1) DK0967986T3 (en)
ES (1) ES2185147T3 (en)
HU (1) HUP0100639A3 (en)
NO (1) NO994339L (en)
PT (1) PT967986E (en)
SK (1) SK120299A3 (en)
WO (1) WO1998040087A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT408946B (en) * 1999-02-18 2002-04-25 Immuno Ag USE OF OROSOMUCOID FOR PRODUCING A PHARMACEUTICAL PREPARATION
AT407485B (en) * 1999-04-14 2001-03-26 Haemosan Erzeugung Pharmazeuti NEW MEDICAL USE OF ALPHA1 ACID GLYCOPROTEIN

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06118723A (en) * 1992-10-02 1994-04-28 Fujitsu Ltd Electrophotographic carrier
JPH06122025A (en) * 1992-10-14 1994-05-06 Komatsu Ltd Followup method for work bending in press brake robot system

Also Published As

Publication number Publication date
JP2001514629A (en) 2001-09-11
DE59805897D1 (en) 2002-11-14
HUP0100639A1 (en) 2001-08-28
AT405241B (en) 1999-06-25
ATE225664T1 (en) 2002-10-15
ATA40997A (en) 1998-11-15
WO1998040087A3 (en) 1998-12-17
EP0967986A2 (en) 2000-01-05
PT967986E (en) 2003-02-28
DK0967986T3 (en) 2003-02-10
ES2185147T3 (en) 2003-04-16
WO1998040087A2 (en) 1998-09-17
CA2283580A1 (en) 1998-09-17
BR9808000A (en) 2000-03-08
SK120299A3 (en) 2000-05-16
EP0967986B1 (en) 2002-10-09
AU6284198A (en) 1998-09-29
NO994339L (en) 1999-11-08
NO994339D0 (en) 1999-09-07

Similar Documents

Publication Publication Date Title
HUP9603064A2 (en) New oral pharmaceutical dosage form
PL341428A1 (en) Oral pharmacological dosage form of prolonged release type
PL322579A1 (en) 2-methyl-thiene-benzodiazeoin prparation for oral administration
HUP9903407A3 (en) Oral pharmaceutical preparation containing ibandronat
PL321538A1 (en) Additional protein of a human interleukin-1 receptor
IL117128A0 (en) Modular patient care system
HK1041489A1 (en) 5-0-Desosaminyl 6-0-methylerythronolide a for use for the preparation of bilogically-active products
IL120654A0 (en) Administration of two liquids to a patient
PL314732A1 (en) S(+)-ethodolac preparations for oral administration
SG42435A1 (en) A new skin preparation composition
IL125743A0 (en) A medicinal preparation
PL307469A1 (en) Preparation for oral administration
GB9604736D0 (en) A pharmaceutical preparation
ZA982073B (en) Pharmaceutical preparation
GB9408053D0 (en) Pharmaceutical preparation
HUP0100223A3 (en) Use of ginkgo biloba extracts for preparing a medicine
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
GB9214634D0 (en) A cosmetic or pharmaceutical preparation
HUP0100639A3 (en) Use of human alpha1-acid glycoprotein for producing a pharmaceutical preparation
AP9801196A0 (en) Pharmaceutical preparation
HUP9904181A3 (en) Sufrace-stabilised pharmaceutical preparation for application on the skin
SI0967986T1 (en) USE OF HUMAN alpha 1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION
NZ307236A (en) Preparation of streptogramins
ZA967542B (en) Pharmaceutical combination preparation comprising keto-profen
IL117465A0 (en) A pharmaceutical use of certain cystine derivatives